Adebrelimab Plus Full-course Neoadjuvant Therapy for Resectable Locally Advanced ESCC (Phase 2)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to ESCC
Related studies linked through entity extraction aliases.
Efficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Study on the Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Nab-Paclitaxel in Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Development and Multicenter Validation of a Novel Bio-Anatomical Staging System for Predicting Survival and Tailoring Adjuvant Therapy in ESCC After Neoadjuvant Chemoimmunotherapy.
- Status
- COMPLETED
- Phase
- N/A
Adebrelimab Neoadjuvant Treatment for Resectable ESCC
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
TAS-102 Plus Radiotherapy in Elderly ESCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR）
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Efficacy and Safety of Tislelizumab and Nab-paclitaxel Combined With Low-dose Radiotherapy in Patients With Stage IVb Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
DCF Combined With Camrelizumab in the Treatment of Esophageal Cancer
- Status
- UNKNOWN
- Phase
- NA